BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33658424)

  • 1. PHENOTYPIC CHARACTERISTICS OF RELAPSED LEIOMYOMA AND SMOOTH MUSCLE TUMORS OF UNCERTAIN MALIGNANCY POTENTIAL IN REPRODUCTIVE WOMEN.
    Kiknadze T; Tevdorashvili G; Muzashvili T; Gachechiladze M; Burkadze G
    Georgian Med News; 2021 Jan; (310):150-156. PubMed ID: 33658424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HISTOPATHOLOGICAL, PROLIFERATIVE, APOPTOTIC AND HORMONAL CHARACTERISTICS OF VARIOUS TYPES OF LEIOMYOMAS.
    Kiknadze T; Tevdorashvili G; Muzashvili T; Gachechiladze M; Burkadze G
    Georgian Med News; 2021 Mar; (312):119-125. PubMed ID: 33964839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine smooth muscle tumors of uncertain malignant potential (STUMP): A retrospective study in a single center.
    Zhang C; Gao J; Lu S; Zhang Y; Zhu H
    Eur J Obstet Gynecol Reprod Biol; 2021 Oct; 265():74-79. PubMed ID: 34467879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience of uterine smooth muscle tumor of uncertain malignant potential in two gynecological centers: Oncological and obstetrical aspects.
    Shim JI; Han AKW; Jeon HJ; Kim ML; Jung YW; Yun BS; Seong SJ; Shin E; Cho YJ; Rha SH
    Eur J Obstet Gynecol Reprod Biol; 2020 Mar; 246():7-13. PubMed ID: 31927240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular prognostication of uterine smooth muscle neoplasms: From CGH array to CINSARC signature and beyond.
    Croce S; Chibon F
    Genes Chromosomes Cancer; 2021 Mar; 60(3):129-137. PubMed ID: 33099852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine smooth muscle tumor analysis by comparative genomic hybridization: a useful diagnostic tool in challenging lesions.
    Croce S; Ribeiro A; Brulard C; Noel JC; Amant F; Stoeckle E; Devouassoux-Shisheborah M; Floquet A; Arnould L; Guyon F; Mishellany F; Garbay D; Cuppens T; Zikan M; Leroux A; Frouin E; Duvillard P; Terrier P; Farre I; Valo I; MacGrogan GM; Chibon F
    Mod Pathol; 2015 Jul; 28(7):1001-10. PubMed ID: 25932961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of matrix metalloproteinases in patients with uterine smooth muscle tumors: an immunohistochemical analysis of MMP-1 and MMP-2 protein expression in leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner-Adler B; Bodner K; Kimberger O; Czerwenka K; Leodolter S; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):182-6. PubMed ID: 15051038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of BCL2 in the recurrence of uterine smooth muscle tumors of uncertain malignant potential.
    Conconi D; Chiappa V; Perego P; Redaelli S; Bovo G; Lavitrano M; Milani R; Dalprà L; Lissoni AA
    Oncol Rep; 2017 Jan; 37(1):41-47. PubMed ID: 28004108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TOP2A copy number and TOP2A expression in uterine benign smooth muscle tumours and leiomyosarcoma.
    Baiocchi G; Poliseli FL; De Brot L; Mantoan H; Schiavon BN; Faloppa CC; Vassallo J; Soares FA; Cunha IW
    J Clin Pathol; 2016 Oct; 69(10):884-9. PubMed ID: 26994023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of allelic loss as an adjuvant tool in evaluation of malignancy in uterine smooth muscle tumors.
    Esposito NN; Hunt JL; Bakker A; Jones MW
    Am J Surg Pathol; 2006 Jan; 30(1):97-103. PubMed ID: 16330948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Histopathological Predictors of Recurrence in Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Multicenter Retrospective Cohort Study of Tertiary Centers.
    Borella F; Cosma S; Ferraioli D; Ray-Coquard I; Chopin N; Meeus P; Cockenpot V; Valabrega G; Scotto G; Turinetto M; Biglia N; Fuso L; Mariani L; Franchi D; Vidal Urbinati AM; Pino I; Bertschy G; Preti M; Benedetto C; Castellano I; Cassoni P; Bertero L
    Ann Surg Oncol; 2022 Dec; 29(13):8302-8314. PubMed ID: 35976464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ki-67 expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignant potential (STUMP) and uterine leiomyosarcomas (LMS).
    Mayerhofer K; Lozanov P; Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K
    Acta Obstet Gynecol Scand; 2004 Nov; 83(11):1085-8. PubMed ID: 15488127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variant type of leiomyomas: 13 years of experience in a single institution.
    Bacanakgil BH; Ilhan G; Kaban I
    Ginekol Pol; 2022; 93(6):444-449. PubMed ID: 34155617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progress in clinicopathologic study on uterine smooth muscle tumor of uncertain malignant potential].
    Deng ZJ; Guo LN
    Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):573-6. PubMed ID: 22169655
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinicopathologic evaluation of uterine smooth muscle tumors of uncertain malignant potential (STUMP): A single center experience.
    Karataşlı V; Çakır İ; Ayaz D; Budak A; Sancı M
    J Gynecol Obstet Hum Reprod; 2019 Oct; 48(8):637-642. PubMed ID: 30898630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine smooth muscle tumors of uncertain malignant potential (STUMP): a clinicopathologic analysis of 16 cases.
    Ip PP; Cheung AN; Clement PB
    Am J Surg Pathol; 2009 Jul; 33(7):992-1005. PubMed ID: 19417585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical update of smooth muscle tumors of the uterus.
    Solomon LA; Schimp VL; Ali-Fehmi R; Diamond MP; Munkarah AR
    J Minim Invasive Gynecol; 2005; 12(5):401-8. PubMed ID: 16213425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinicopathologic study of uterine smooth muscle tumours of uncertain malignant potential (STUMP).
    Ng JS; Han A; Chew SH; Low J
    Ann Acad Med Singap; 2010 Aug; 39(8):625-8. PubMed ID: 20838704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ["STUMP" (smooth muscle tumour of uncertain malignant potential), a tumour of the uterus in pregnancy--a diagnostic and therapeutic challenge].
    Clauss S; Höller S; Hegi L; Blum R; Hösli I
    Z Geburtshilfe Neonatol; 2010 Apr; 214(2):74-7. PubMed ID: 20411475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.